BLEPH®-10 solution is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma:

Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus Muenzae, Klebsiella species, and Enterobacter species.

Topically applied sulfonamides do not provide adequate coverage against Neisseria species, Serratia marcescens and Pseudomonas aeruginosa. A significant percentage of staphylococcal isolates are completely resistant to sulfa drugs.

For conjunctivtis and other superficial ocular infections: Instill one or two drops into the conjunctival sac(s) of the affected eye(s) every two to three hours initially. Dosages may be tapered by increasing the time interval between doses as the condition responds. The usual duration of treatment is seven to ten days.

For Trachoma: Instill two drops into the conjunctival sac(s) of the affected eye(s) every two hours. Topical administration must be accompanied by systemic administration.

BLEPH ®-10 (sulfacetamide sodium ophthalmic solution, USP) 10% is supplied sterile in plastic bottles in the following sizes:

5 mL--NDC 11980-011-05

15 mL--NDC 11980-011-15

Storage: Store between 8-30°C (46-86°F).

Keep container tightly closed. Protect from light. Sulfonamide Solutions, on long standing. will darken in color and should be discarded.

CAUTION: Federal (U.S.A.) law prohibits dispensing without prescription.

®Marks owned by Allergan, Inc.

Bookmark this page: